Caspase activation, inhibition, and reactivation: A mechanistic view
Caspases, a unique family of cysteine proteases, execute programmed cell death (apoptosis). Caspases exist as inactive zymogens in cells and undergo a cascade of catalytic activation at the onset of apoptosis. The activated caspases are subject to inhibition by the inhibitor‐of‐apoptosis (IAP) famil...
Saved in:
Published in | Protein science Vol. 13; no. 8; pp. 1979 - 1987 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Bristol
Cold Spring Harbor Laboratory Press
01.08.2004
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Caspases, a unique family of cysteine proteases, execute programmed cell death (apoptosis). Caspases exist as inactive zymogens in cells and undergo a cascade of catalytic activation at the onset of apoptosis. The activated caspases are subject to inhibition by the inhibitor‐of‐apoptosis (IAP) family of proteins. This inhibition can be effectively removed by diverse proteins that share an IAP‐binding tetrapeptide motif. Recent structural and biochemical studies have revealed the underlying molecular mechanisms for these processes in mammals and in Drosophila. This paper reviews these latest advances. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.04789804. Reprint requests to: Yigong Shi, Department of Molecular Biology, Lewis Thomas Laboratory, Princeton University, Princeton, NJ 08544, USA; e-mail: yshi@molbio.princeton.edu; fax: (609) 258-6730. |
ISSN: | 0961-8368 1469-896X |
DOI: | 10.1110/ps.04789804 |